Care Access Acquires Brazil-Based Clinical Research Center CEMEC
Care Access, a globally recognized healthcare and clinical research organization, has announced the successful acquisition of Centro Multidisciplinar de Estudos Clínicos (CEMEC), a leading clinical research center based in Brazil. This acquisition marks another significant milestone in Care Access’ broader mission to enhance the accessibility of clinical trials and advanced medical research across Latin America. The move aligns with the company’s continued efforts to create a more inclusive and accessible global research network, ensuring more communities can benefit from innovative treatments and therapies.
CEMEC, headquartered in São Bernardo do Campo, Brazil, has established itself as one of the country’s foremost research institutions, specializing in large-scale multicenter clinical trials. With state-of-the-art facilities and a highly skilled multidisciplinary team, CEMEC has conducted over 100 clinical studies spanning 18 therapeutic areas. The organization has played a pivotal role in shaping Brazil’s research landscape, conducting phase 2, 3, and 4 clinical trials in both outpatient and inpatient settings. Its expertise and commitment to high-quality research align seamlessly with Care Access’ vision of expanding healthcare and research accessibility to underserved and remote populations.
Expanding Research Opportunities in Latin America
The acquisition of CEMEC is part of Care Access’ long-term strategic initiative to extend its research capabilities throughout Latin America. This strategy includes several key expansions:
- The 2022 acquisition of Instituto Brasil de Pesquisa Clínica (IBPClin), another major clinical research center in Brazil.
- The 2024 establishment of a new Care Access research center in Xerém, located in the Caxias district of Rio de Janeiro State.
- The planned opening of an additional research center in São Paulo in May 2025.
- Future expansion plans for new research centers in Brazil, Argentina, and other Latin American nations.
- The introduction of a fleet of mobile health clinics and a logistics hub designed to bring clinical trials and medical research to underrepresented and hard-to-reach communities across the region.
Enhancing Clinical Research Through Strategic Partnerships
By integrating CEMEC into its global network, Care Access aims to strengthen the impact of clinical research in Latin America. This partnership will help support CEMEC’s ongoing mission to improve research accessibility while simultaneously accelerating Care Access’ objectives of providing cutting-edge healthcare and research opportunities to communities that need them the most.
“Care Access has a long-standing reputation for introducing innovative clinical trial delivery methods to make research more accessible and convenient for communities everywhere,” said Rodrigo Pavani, co-owner of CEMEC. “We are excited to bring these capabilities to our research center in Brazil, where many individuals struggle to access clinical trial opportunities. This partnership will allow us to reach a larger population and enhance medical advancements in our country.”
The Future of Medicine: A Commitment to Accessible Healthcare
One of Care Access’ flagship initiatives is the Future of Medicine program, which is dedicated to accelerating patient enrollment and improving participation in clinical trials. This initiative is particularly focused on making cutting-edge treatments more widely available by increasing outreach to historically underserved communities. The program achieves its goals by:
- Expanding research education and healthcare services within local communities.
- Bringing clinical trial opportunities directly to patients through mobile health units and community-based research sites.
- Reducing barriers to participation in clinical research and improving the diversity of trial participants, ensuring that study results reflect real-world populations.
“Growing our presence in Latin America is a strategic priority for us,” said Ahmad Namvargolian, CEO and Co-Founder of Care Access. “Some of the world’s leading research institutions are based in this region, and clinical research opportunities are rapidly increasing. CEMEC represents the gold standard for clinical research excellence in Brazil. By combining its established presence and expertise with Care Access’ strategic and operational resources, we will bring high-quality research and healthcare services to even more communities, ultimately improving health outcomes for countless individuals.”
Strengthening Capabilities and Community Impact
This acquisition is expected to significantly enhance CEMEC’s capabilities in the following ways:
- Community-Based Research Expansion: Care Access’ unique model of conducting research within local communities will make clinical trial participation more convenient and accessible for residents of São Paulo and surrounding regions.
- Increased Healthcare Access: Individuals in CEMEC’s service areas will gain access to free health screenings, research education, and medical services provided through Care Access’ Future of Medicine program.
- Enhanced Operational Support: With access to Care Access’ extensive network of over 1,000 clinical research professionals worldwide, CEMEC will benefit from additional expertise and resources to drive its research initiatives forward.
About Care Access
Care Access is a global leader in clinical research and healthcare services, committed to making the future of medicine more inclusive and accessible for all. The company focuses on improving public health by connecting individuals to the healthcare resources they need, including research participation opportunities that drive medical innovation.
With a network of more than 200 research centers worldwide, a team of hundreds of traveling medical professionals, and a fleet of over 150 mobile health clinics, Care Access works in collaboration with local communities to ensure that critical medical research reaches those who need it most. Through its Future of Medicine program, the company offers free health screenings, clinical trial education, and other essential healthcare services to the public. Additionally, its Difference Makers initiative supports local organizations and leaders dedicated to improving community health and well-being.
